Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2012

01-11-2012 | Original Paper

Aging, Prospective Memory, and Health-Related Quality of Life in HIV Infection

Authors: Katie Doyle, Erica Weber, J. Hampton Atkinson, Igor Grant, Steven Paul Woods, The HIV Neurobehavioral Research Program (HNRP) Group

Published in: AIDS and Behavior | Issue 8/2012

Login to get access

Abstract

HIV infection and older age are each independently associated with lower health-related quality of life (HRQoL) and deficits in prospective memory (PM), which is a distinct aspect of cognition involving the ability to “remember to remember” to do something at a future occasion. The present study investigated associations between PM and HRQoL in 72 older (≥50 years) and 41 younger (≤40 years) HIV-infected adults. Self-reported PM complaints predicted HRQoL across the entire sample, but there was a significant interaction between performance-based PM and age group on HRQoL, such that lower time-based PM was associated with lower HRQoL only in the younger cohort. Within the younger group, time-based and self-reported PM significantly predicted mental HRQoL independent of other risk factors (e.g. depression). These findings suggest that PM plays a unique role in HRQoL outcomes among younger persons living with HIV infection and support the examination of other age-related factors (e.g. effective use of compensatory strategies) that may regulate the adverse impact of PM on everyday functioning.
Literature
1.
Centers for Disease Control. HIV/AIDS surveillance report, 2005. Atlanta: US Department of Health and Human Services, CDC; 2007. p. 1–63.
2.
3.
Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815–26.PubMedCrossRef
4.
Piette J, Wachtel TJ, Mor V, Mayer K. The impact of age on the quality of life in persons with HIV infection. J Aging Health. 1995;7(2):163–7.PubMedCrossRef
5.
Zahran HS, Kobau R, Moriarty DG, et al. Health-related quality of life surveillance—United States, 1993–2002. MMWR Surveill Summ. 2005;54:1–35.PubMed
6.
Chesney MA, Chambers DB, Taylor JM, Johnson LM. Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S185–93.PubMed
7.
Avis NE, Smith KW. Quality of life in older adults with HIV disease. Res Aging. 1998;20(6):822–45.CrossRef
8.
Hays RB, Catania JA, McKusick L, Coates TJ. Help-seeking for AIDS-related concerns: a comparison of gay men with various HIV diagnoses. Am J Community Psychol. 1990;18(5):743–55.PubMedCrossRef
9.
Fleishman JA, Sherbourne CD, Crystal S, et al. Coping, conflictual social interactions, social support, and mood among HIV-infected persons. HCSUS consortium. Am J Community Psychol. 2000;28(4):421–53.PubMedCrossRef
10.
Swindells S, Mohr J, Justis JC, et al. Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS. 1999;10(6):383–91.PubMedCrossRef
11.
Schmitz MF, Crystal F. Social relations, coping, and psychological distress among persons with HIV/AIDS. J Appl Soc Psychol. 2000;30(4):665–85.CrossRef
12.
Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.PubMedCrossRef
13.
Heaton RK, Franklin D, Clifford D, et al. Persistence and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: the CHARTER study. J Neurovirol. 2009;15(Suppl 1):34–5.
14.
Becker JT, Lopes OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18:S11–8.PubMedCrossRef
15.
Larussa D, Lorenzini P, Cingolani A, et al. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1 infected patients. AIDS Res Hum Retroviruses. 2006;22:386–92.PubMedCrossRef
16.
Valcour B, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV cohort. Neurology. 2004;63:822–7.PubMedCrossRef
17.
Valcour B, Shikuma C, Shiramizu B, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii HIV with aging cohort. J Neuroimmunol. 2004;157:197–202.PubMedCrossRef
18.
Cherner M, Ellis RJ, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004;18(Suppl 1):S27–34.PubMed
19.
Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007;13(3):203–9.PubMedCrossRef
20.
Sacktor N, Skolasky RL, Cox C, et al. Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol. 2010;16(5):335–41.PubMedCrossRef
21.
Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152–68.PubMedCrossRef
22.
Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.PubMedCrossRef
23.
Ettenhofer ML, Foley J, Behdin N, Levine AJ, Castellon SA, Hinkin CH. Reaction time variability in HIV-positive individuals. Arch Clin Neuropsychol. 2010;25(8):791–8.PubMedCrossRef
24.
Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200–9.PubMedCrossRef
25.
Tozzi V, Balestra P, Galgani S, et al. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses. 2003;19(8):643–52.PubMedCrossRef
26.
Osowiecki DM, Cohen RA, Morrow KM, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14(10):1327–32.PubMedCrossRef
27.
Zogg JB, Woods SP, Weber E, Doyle K, Grant I, the HNRC Group. Are time- and event-based prospective memory comparably affected in HIV infection? Arch Clin Neuropsychol. 2011;26:250–9.PubMedCrossRef
28.
Gupta S, Woods SP, Weber E, Dawson MS, Grant I, The HNRC Group. Is prospective memory a dissociable cognitive function in HIV infection? J Clin Exp Neuropsychol. 2010;32(8):898–908.PubMedCrossRef
29.
Woods SP, Morgan EE, Marquie-Beck J, et al. Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol. 2006;19(4):217–21.PubMedCrossRef
30.
Woods SP, Carey CL, Moran LM, et al. Frequency and predictors of self-reported memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 2007;22(2):187–95.PubMedCrossRef
31.
Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I, The HNRC Group. Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol. 2006;28(4):536–48.PubMedCrossRef
32.
Martin EM, Nixon H, Pitrack DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Neuropsychol. 2007;29(5):496–504.PubMedCrossRef
33.
Weber E, Woods SP, Delano-Wood L, et al. An examination of the age-prospective memory paradox in HIV-infected adults. J Clin Exp Neuropsychol. 2011;33(10):1108–18.PubMedCrossRef
34.
Woods SP, Dawson, Weber E, Grant I, The HNRC Group. The semantic relatedness of cue-intention pairings influence event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol. 2010;32(4):398–407.PubMedCrossRef
35.
Woods SP, Iudicello JE, Moran LM, et al. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110–7.PubMedCrossRef
36.
Contardo C, Black AC, Beauvais J, Dieckhaus K, Rosen MI. Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol. 2009;24:547–54.PubMedCrossRef
37.
Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23(3):257–70.PubMedCrossRef
38.
Woods SP, Dawson MS, Weber E, et al. Timing is everything: antiretroviral non-adherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009;15(1):42–52.PubMedCrossRef
39.
Woods SP, Weber E, Weisz M, Twamley EW, Grant I, The HNRC Group. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011;56(1):77–84.PubMedCrossRef
40.
Center for Disease Control. HIV/AIDS surveillance report, 2007. Atlanta: US Department of Health and Human Services, CDC; 2009. p. 1–54.
41.
Stoff DM. Mental health research in HIV/AIDS and aging: problems and prospects. AIDS. 2004;18(Suppl 1):S3–10.PubMed
42.
The Psychological Corporation. Manual for the Wechsler Test of Adult Reading (WTAR). San Antonio: Author; 2001.
43.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRef
44.
Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
45.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: a user’s manual. Boston: The Health Institute, New England Medical Center; 1994.
46.
Lamping DL. Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection. Psychol Health. 1994;9(1–2):31–49.CrossRef
47.
Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparision of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14(1):141–50.PubMedCrossRef
48.
Woods SP, Moran LM, Dawson MS, Carey CL, Grant I, the HNRC Group. Psychometric characteristics of the memory for intentions screening test. Clin Neuropsychol. 2008;22(5):864–78.PubMedCrossRef
49.
Raskin S, Buckheit C, Sherrod C. Memory for intentions test (MIsT). Lutz: Psychological Assessment Resources, Inc.; 2010.
50.
Smith G, Della Sala S, Logie RH, Maylor EA. Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory. 2000;8(5):311–2.PubMedCrossRef
51.
Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH. The prospective and retrospective memory questionnaire (PRMQ): normative data and latent structure in a large non-clinical sample. Memory. 2003;11(3):261–75.PubMedCrossRef
52.
Smith HJ, Taylor R, Mitchell A. A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart. 2000;84(4):390–4.PubMedCrossRef
53.
Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.PubMedCrossRef
54.
Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychology Press; 1985.
55.
Woods SP, Carey CL, Tröster AI, Grant I, The HNRC Group. Action (verb) generation in HIV-1 infection. Neuropsychologia. 2005;43(8):1144–51.PubMedCrossRef
56.
Delis DC, Kramer JH, Kaplan E, Ober BA. The California verbal learning test. 2nd ed. San Antonio: The Psychological Corporation; 2000.
57.
Culbertson WC, Zillmer EA. The Tower of London DX (TOL-DX) manual. North Tonawanda: Multi-Health Systems; 2001.
58.
Psychological Corporation. WAIS-III and WMS-III technical manual. San Antonio: Author; 1997.
59.
Kløve H. Grooved pegboard. Indiana: Lafayette Instruments; 1963.
60.
Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759–78.PubMedCrossRef
61.
World Health Organization. Composite international diagnostic interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.
62.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author; 1994.
63.
McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego: Educational and Industrial Testing Services; 1981.
64.
Kliegel M, Jager T, Altgasen M, Shum D. Clinical neuropsychology of prospective memory. In: Kliegel M, McDaniel MA, Einstein GO, editors. Prospective memory: cognitive, neuroscience, developmental, and applied perspectives. New York: Taylor and Francis Group/Lawrence Erlbaum Associates; 2008. p. 283–308.
65.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.PubMedCrossRef
66.
Dijkers MP. Quality of life after traumatic brain injury: a review of research approaches and findings. Arch Phys Med Rehabil. 2004;85(4 Suppl 2):S21–35.PubMedCrossRef
67.
Smith KW, Larson MJ. Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse. 2003;29(2):323–35.PubMedCrossRef
68.
Holloway F, Carson J. Quality of life in severe mental illness. Int Rev Psychiatry. 2002;14(3):175–84.CrossRef
Metadata
Title
Aging, Prospective Memory, and Health-Related Quality of Life in HIV Infection
Authors
Katie Doyle
Erica Weber
J. Hampton Atkinson
Igor Grant
Steven Paul Woods
The HIV Neurobehavioral Research Program (HNRP) Group
Publication date
01-11-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0121-x

Other articles of this Issue 8/2012

AIDS and Behavior 8/2012 Go to the issue

Original Paper

Labor Force Participation and Health-Related Quality of Life in HIV-Positive Men Who Have Sex with Men: The Multicenter AIDS Cohort Study

Original Paper

Development of a New Instrument for the Assessment of Psychological Predictors of Well-being and Quality of Life in People with HIV or AIDS

Original Paper

Postnatal Depression Symptoms are Associated with Increased Diarrhea Among Infants of HIV-Positive Ghanaian Mothers

Original Paper

Lower Cognitive Reserve Among Individuals with Syndromic HIV-Associated Neurocognitive Disorders (HAND)

Original Paper

Recent Trauma is Associated with Antiretroviral Failure and HIV Transmission Risk Behavior Among HIV-Positive Women and Female-Identified Transgenders

Substantive Review

Stress and Coping in Women Living with HIV: A Meta-Analytic Review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits